With a robust background in technology and healthcare investments, the fund manager has successfully executed over 50 deals across North America and Europe. Emphasizing a data-driven approach, they have built a diverse portfolio that includes both early-stage and growth investments. Noteworthy exits in the biotechnology sector showcase their strategic acumen and ability to identify high-potential opportunities. Their operator-first style enhances collaboration with portfolio companies, driving sustained growth and innovation.